Abnormal glucose tolerance in children with cystic fibrosis: The predictive role of continuous glucose monitoring system

European Journal of Endocrinology

Volumn 162, Issue 4, 2010, Pages 705-710

  Schiaffini, Riccardo ^a   Brufani, Claudia ^a   Russo, Beatrice ^a   Fintini, Danilo ^a   Migliaccio, Antonella ^a   Pecorelli, Lia ^a   Bizzarri, Carla ^a   Lucidi, Vincenzina ^a   Cappa, Marco ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING SYSTEM; CONTROLLED STUDY; CYSTIC FIBROSIS; DETERIORATION; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MALE; MONITORING; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADOLESCENT; AREA UNDER CURVE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CYSTIC FIBROSIS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS;

EID: 77950309283     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1020     Document Type: Article

References (28)

1. Lanng S, Thorsteinnsson B, Paciot F, Marshall MO, Madsen HO, Schwartz M, Nerup J & Koch C. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatrica 1993 82 150-154.
2. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG & Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. Journal of Pediatrics 2005 146 681-687.
3. Moran A, Dunitz J, Nathan B, Saeed A, Holme B & Thomas W. Cystic fibrosis related diabetes: current trends in prevalence, incidence and mortality. Diabetes Care 2009 32 1626-1631.
4. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, De Blic J, Lenoir G & Robert JJ. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. Journal of Pediatrics 2008 152 540-545.
5. Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Lévesque R, Perrier J, Poisson D, Karelis AD, Chiasson JL & Rabasa-Lhoret R. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. Journal of Cystic Fibrosis 2007 6 376-383.
6. Milla CE, Warwik WJ & Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. American Journal of Respiratory and Critical Care Medicine 2000 162 891-895.
7. Schaedel C, De Monestrol I, Hjelthe L, Johannesson M, Kornfält R, Lindblad A, Strandvik B, Wahlgren L & Holmberg L. Predictors of deterioration of lung function in cystic fibrosis. Pediatric Pulmonology 2002 33 483-491.
8. Moran A, Doherty L, Wang X & Thomas W. Abnormal glucose metabolism in cystic fibrosis. Journal of Pediatrics 1998 133 10-17.
9. O'Riordan SMP, Robinson PD, Donaghue KC, Moran A & ISPAD Clinical Practice Consensus Guidelines 2008. Management of cystic fibrosis-related diabetes. Pediatric Diabetes 2008 9 338-344.
10. Franzese A, Valerio G, Buono P, Spagnuolo MI, Sepe A, Mozzillo E, De Simone I & Raia V. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. Journal of Pediatric Endocrinology & Metabolism 2008 21 109-116.
11. Dobson L, Sheldon CD & Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabetic Medicine 2004 21 691-696.
12. Jefferies C, Solomon M, Perlman K, Sweezey N & Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. Journal of Pediatrics 2005 147 396-398.
13. Moreau F, Weiller MA, Rosner V, Weiss L, Hasselmann M, Pinget M, Kessler R & Kessler L. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Hormone and Metabolic Research 2008 40 502-506.
14. O'Riordan SM, Hindmarsh P, Hill NR, Matthews DR, George S, Greally P, Canny G, Slattery D, Murphy N, Roche E, Costigan C & Hoey H. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care 2009 32 1020-1022.
15. Dobson L, Sheldon CD & Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003 26 1940-1941.
16. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008 31 S12-S54.
17. Cole TJ, Bellizzi MC, Flegal KM & Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000 320 1-6.
18. Mastrototaro J. The Minimed continuous glucose monitoring system (CGMS). Journal of Pediatric Endocrinology and Metabolism 1999 12 751-758.
19. Matsuda M & De Fronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470.
20. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC & Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 1663-1672.
21. Lanng S, Hansen A, Thorsteinsson B, Nerup J & Koch C. Glucose tolerance with cystic fibrosis: five-year prospective study. BMJ 1995 311 655-659.
22. Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L & Rabasa-Lhoret R. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes & Metabolism 2008 34 568-573.
23. 1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care 2000 23 126.
24. Lanng S, Thorsteinsson B, Nerup J & Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatrica 1994 83 849-853.
25. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ & Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Archives of Disease in Childhood 2002 87 430-431.
26. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H & the CFRDT Study Group. Insulin therapy to improve BMI in cystic fibrosis related diabetes without fasting hyperglycemia: results of the CFRDT trial. Diabetes Care 2009 32 1783-1788.
27. Bizzarri C, Lucidi V, Ciampalini P, Bella S, Russo B & Cappa M. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. Journal of Endocrinological Investigation 2006 29 RC1-RC4.
28. Mozzillo E, Franzese A, Valerio G, Sepe A, De Simone I, Mazzarella G, Ferri P & Raia V. One-year glargine treatment can improve the curse of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatric Diabetes 2008 10 162-167.